Bio-Techne (BSP:T1CH34) Cyclically Adjusted Book per Share: R$1.99 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:T1CH34 Bio-Techne Corp BSP:T1CH34
80 GF Score
Price R$12.24
GF Value R$12.22
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Bio-Techne Cyclically Adjusted Book per Share?

Bio-Techne BSP:T1CH34 +1.16% 80 Cyclically Adjusted Book per Share is R$1.99 as of Mar. 2026. GuruFocus rates BSP:T1CH34 with a GF Score™ of 80/100 and a GF Value™ of R$12.22 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bio-Techne's adjusted book value per share for the three months ended in Mar. 2026 was R$2.323. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$1.99 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bio-Techne's average Cyclically Adjusted Book Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.80% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Bio-Techne was 32.30% per year. The lowest was 9.20% per year. And the median was 13.15% per year.

As of today (2026-08-01), Bio-Techne's current stock price is R$12.24. Bio-Techne's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was R$1.99. Bio-Techne's Cyclically Adjusted PB Ratio of today is 6.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Techne was 19.03. The lowest was 3.78. And the median was 7.95.


Bio-Techne  (BSP:T1CH34) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bio-Techne's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=12.24/1.99
=6.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Techne was 19.03. The lowest was 3.78. And the median was 7.95.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bio-Techne Cyclically Adjusted Book per Share Related Terms


Bio-Techne Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Cyclically Adjusted Book per Share Chart

Bio-Techne Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 1.47 1.35 1.86 1.90

Bio-Techne Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.10 1.90 1.80 2.03 1.99

BSP:T1CH34 vs CYTK, SMMT, BMRN: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Bio-Techne's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Techne Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Cyclically Adjusted PB Ratio falls into.


BSP:T1CH34
80GF Score
Bio-Techne Corp BSP:T1CH34
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Techne's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.323/330.2130*330.2130
=2.323

Current CPI (Mar. 2026) = 330.2130.

Bio-Techne Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.673 241.018 0.922
201609 0.651 241.428 0.890
201612 0.667 241.432 0.912
201703 0.634 243.801 0.859
201706 0.698 244.955 0.941
201709 0.670 246.819 0.896
201712 0.731 246.524 0.979
201803 0.770 249.554 1.019
201806 0.902 251.989 1.182
201809 1.005 252.439 1.315
201812 0.940 251.233 1.236
201903 0.970 254.202 1.260
201906 0.987 256.143 1.272
201909 1.058 256.759 1.361
201912 1.182 256.974 1.519
202003 1.379 258.115 1.764
202006 1.553 257.797 1.989
202009 1.678 260.280 2.129
202012 1.683 260.474 2.134
202103 1.861 264.877 2.320
202106 1.681 271.696 2.043
202109 1.836 274.310 2.210
202112 2.041 278.802 2.417
202203 1.811 287.504 2.080
202206 1.828 296.311 2.037
202209 1.950 296.808 2.169
202212 2.034 296.797 2.263
202303 2.085 301.836 2.281
202306 2.018 305.109 2.184
202309 2.077 307.789 2.228
202312 2.041 306.746 2.197
202403 2.122 312.332 2.243
202406 2.348 314.175 2.468
202409 2.485 315.301 2.603
202412 2.677 315.605 2.801
202503 2.471 319.799 2.551
202506 2.289 322.561 2.343
202509 2.256 324.800 2.294
202512 2.346 324.054 2.391
202603 2.323 330.213 2.323

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of R$1.99 mean?
Bio-Techne (BSP:T1CH34) has a Cyclically Adjusted Book per Share of R$1.99 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Techne and its competitors.
Is Bio-Techne's Cyclically Adjusted Book per Share too high?
Bio-Techne's current Cyclically Adjusted Book per Share is R$1.99. Overall, Bio-Techne has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Cyclically Adjusted Book per Share compare to CYTK and SMMT?
Bio-Techne's Cyclically Adjusted Book per Share of R$1.99 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Techne and its competitors. Bio-Techne's current Cyclically Adjusted Book per Share is R$1.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Based on GuruFocus' analysis, Bio-Techne (BSP:T1CH34) is currently considered Fairly Valued. The stock's GF Value™ is R$12.22, compared to a current price of R$12.24 — trading 0.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is R$1.99. Bio-Techne's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bio-Techne (BSP:T1CH34), the current Cyclically Adjusted Book per Share is R$1.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (BSP:T1CH34) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be overvalued. The current stock price of R$12.24 is trading 0.2% above its estimated GF Value™ of R$12.22. GuruFocus considers Bio-Techne to be Fairly Valued.

Key valuation signals for BSP:T1CH34:

  • Cyclically Adjusted Book per Share: R$1.99
  • GF Value™: R$12.22 vs. price of R$12.24 (0.2% above fair value)
  • GF Score™: 80/100 with 8 warning signs

No single metric tells the full story. See the BSP:T1CH34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio-Techne Business Description

Other Exchanges TECH:USATE1:Germany
Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
80GF Score

Get the complete analysis for BSP:T1CH34

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$12.24
Price
R$12.22
GF Value